An Adaptive Prenatal Intervention to Increase Childhood Vaccinations
NCT ID: NCT05795855
Last Updated: 2026-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
770 participants
INTERVENTIONAL
2024-04-27
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaccine Acceptance in Pregnant Minority Women
NCT01740310
Improving the Health of Parents and Their Adolescent and Transition-age Youth With Intellectual and Developmental Disabilities
NCT05986305
Protecting Pregnant Women From Infectious Diseases
NCT01761799
Peer Education as a Strategy to Promote Vaccine Acceptance
NCT05875779
EngagINg the COmmunity to Reduce Preterm Birth Via Adherence To an Individualized Prematurity Prevention Plan
NCT04933812
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the proposed study, ADEPT will be implemented and evaluated in diverse prenatal care practices in North Carolina. Study prenatal care practices will be randomized to the ADEPT intervention or standard of care to pregnant individuals. Individuals receiving prenatal care at a clinic implementing ADEPT will be screened for vaccination intention following the provider recommendation. Vaccine-hesitant pregnant individuals will be offered enrollment into a nested sub-study designed to assess the implementation of the ADEPT intervention. After the pregnant individuals in the intervention and control arms give birth, the researchers will assess their children's vaccination outcomes at birth, 2, 4, 6, and 12 months using data from the North Carolina Immunization Registry (NCIR). The primary study outcome is the difference in timely childhood vaccination at 2 months between the intervention and control arms. In addition, maternal vaccination data will be collected from NCIR for vaccines during pregnancy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ADEPT
Individuals receiving prenatal care at a practice that was randomized to deliver the ADEPT intervention.
ADEPT
Prenatal providers will participate in trainings that will lay the foundation for an effective vaccination recommendation. After the completion of training, prenatal care providers will begin making recommendations promoting the importance of maternal and childhood vaccinations to pregnant individuals, as part of routine prenatal care. The core component of ADEPT is prenatal provider training to enable a vaccination recommendation, encouraging pregnant individuals to receive vaccines during pregnancy and for their child after birth. Pregnant individuals who remain vaccine hesitant despite the provider recommendation, will be eligible to receive the adaptive components of ADEPT in the form of evidence-based educational materials on vaccinations and phone consultations with a vaccine navigator to discuss residual concerns.
Standard of Care
Individuals receiving prenatal care at a practice that was randomized to deliver the standard of care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ADEPT
Prenatal providers will participate in trainings that will lay the foundation for an effective vaccination recommendation. After the completion of training, prenatal care providers will begin making recommendations promoting the importance of maternal and childhood vaccinations to pregnant individuals, as part of routine prenatal care. The core component of ADEPT is prenatal provider training to enable a vaccination recommendation, encouraging pregnant individuals to receive vaccines during pregnancy and for their child after birth. Pregnant individuals who remain vaccine hesitant despite the provider recommendation, will be eligible to receive the adaptive components of ADEPT in the form of evidence-based educational materials on vaccinations and phone consultations with a vaccine navigator to discuss residual concerns.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton pregnancy (excludes twins, triplets, etc.)
* No known fetal congenital malformations or genetic abnormalities
* Not at known risk for preterm birth
* In late second trimester during study recruitment period
* Receive prenatal care at one of the study practices
* Eligible to receive adaptive components of ADEPT (vaccine-hesitant after provider recommendation)
* At least 18 years of age
* Provide informed consent
* Agree to participate in surveys and in-depth interview
* Agree for child's vaccination outcomes to be extracted from the North Carolina Immunization Registry (NCIR)
* Plan to stay in North Carolina for at least 3 months after delivery
Exclusion Criteria
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Emory University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lavanya Vasudevan
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lavanya Vasudevan, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
Emory University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke Health System
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Vasudevan L, Porter RM, Campos I, Turner EL, Stinnett SS, Zullig LL, Walter EB, Swamy GK, Bednarczyk RA, Orenstein WA, Gray B. An ADaptivE PrenaTal (ADEPT) intervention to increase childhood vaccinations: Protocol for a cluster randomized trial and nested mixed methods evaluation. PLoS One. 2024 Nov 21;19(11):e0313742. doi: 10.1371/journal.pone.0313742. eCollection 2024.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00005431
Identifier Type: OTHER
Identifier Source: secondary_id
STUDY00005457
Identifier Type: OTHER
Identifier Source: secondary_id
STUDY00005432
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.